The calcium paradox
In 2011, the British Medical Journal published an analysis that startled a lot of people: women taking calcium supplements to protect their bones appeared to face a higher risk of heart attack and stroke than women who did not take them. Millions of people in North America take calcium and vitamin D after menopause to prevent osteoporosis — yet in some people, the calcium seems to end up in the walls of arteries instead of in the skeleton it was meant for. That puzzle is often called the “calcium paradox,” and vitamin K2 is a big part of the answer.
Osteoporosis is common and silent. Roughly one in five women over 50 is diagnosed with it, and men are not spared — about one in eight men over 70 will develop it. There are usually no symptoms in the early stages; the first sign is often a fracture from a minor fall. Over time, it can steal as much as six inches of height. Calcium and vitamin D alone have not delivered the bone protection the public hoped for — because where calcium goes matters as much as how much you take. Think of vitamin K2 as a traffic director: it tells calcium where it belongs (our bones and teeth) and keeps it out of where it doesn’t (arteries and soft tissue).
When calcium lands in the wrong place
Because osteoporosis means bones are losing calcium, conventional wisdom says: take more of it — sometimes up to 2,000 mg a day, in whatever “best absorbed” form the marketing describes. But dairy foods and an ordinary diet already supply a good deal of calcium, and cardiovascular disease remains the number one killer in North America. Atherosclerosis is the hardening and narrowing of the arteries as plaque and calcium build up in their walls. Blood flow is restricted, which can cause angina (chest pain) and shortness of breath — or nothing noticeable at all for years, until a heart attack announces it.
What about vitamin D?
Vitamin D is a fat-soluble vitamin that increases calcium absorption from the intestines, and it is genuinely valuable for immune and bone health. But vitamin D by itself does not decide where the absorbed calcium ends up. Some researchers believe that when vitamin K2 is lacking, generous vitamin D and calcium intake can actually add to arterial calcification. The practical conclusion many clinicians have drawn is simple: calcium, vitamin D3 and vitamin K2 belong together — D helps you absorb calcium, and K2 helps direct it. That is why vitamin D3 and K2 are so often paired in well-designed formulas.
How vitamin K2 works behind the scenes
Vitamin K2 activates a family of proteins that move calcium around the body. One is osteocalcin, the most abundant protein in bone after collagen. Once activated by K2, osteocalcin draws calcium into bones and teeth, where it is needed. Another is matrix Gla protein (MGP), which works in the opposite direction — it helps keep calcium out of arteries, veins and other soft tissues. When K2 is in short supply, neither protein is switched on properly, and calcium can deposit where it doesn’t belong: in arteries and joints, and as stones in the kidneys and gallbladder. When K2 is adequate, the result is the combination we want — strong bones and flexible arteries.
Why modern diets run short of K2
K2 is not stored in the body in large amounts, and unlike vitamin K1 it is not efficiently recycled — a diet with almost no vitamin K can run K2 down within about a week. Historically, K2 came from the animals we ate: it forms when animals convert the K1 in green pasture into K2 in their tissues, milk and eggs. But over the last century, North American poultry, eggs, meat and dairy have shifted to confined, grain-fed production. When we removed animals from pasture, we largely removed K2 from our own diet.
Poor vitamin K status has been associated in research with a long list of problems — osteoporosis, arterial calcification, dental issues, kidney stones and more — which is one reason interest in this once-ignored vitamin keeps growing.
Choosing a K2 supplement: MK-7 or MK-4?
Vitamin K2 comes in several forms. The two used in supplements are MK-4 and MK-7. MK-4 stays in the body only a few hours. MK-7 — the form produced by bacterial fermentation, the same form found in the Japanese fermented food natto — lasts a few days. For a once-a-day supplement, MK-7 is generally the practical choice.
A 2025 research update
Interest in K2 is no longer just theory. In a one-year clinical trial published in the journal Nutrients in February 2025, 165 women with low vitamin K status took either 180 µg of MK-7 daily or a placebo. Blood levels of inactive MGP — a marker of poor vitamin K status — fell significantly in the MK-7 group, and among postmenopausal women the worsening of arterial stiffness over the year was significantly smaller than with placebo. The women whose arteries were stiffest at the start also saw a modest improvement in blood pressure. It is one trial, and more research is needed — but it points in the same direction as the mechanism described above.
One important caution
Vitamin K works closely with blood clotting. If you take a blood thinner such as warfarin, do not start or stop any vitamin K supplement without talking to your doctor first, because vitamin K can change how that medication works.
This information is educational only and is not intended to replace the medical advice of your doctor. Please consult your doctor for advice about a specific medical condition.
References: Bolland MJ et al., British Medical Journal, 2011 (calcium supplements and cardiovascular events) · Kate Rheaume-Bleue, Vitamin K2 and the Calcium Paradox · 2025 MK-7 trial (see working notes).
Thanks for sharing this information. It answered a question I had.